UP 202-56, an adenosine analogue, selectively acts via A1 receptors to significantly decrease noxiously-evoked spinal c-Fos protein expression.

Saved in:
Bibliographic Details
Title: UP 202-56, an adenosine analogue, selectively acts via A1 receptors to significantly decrease noxiously-evoked spinal c-Fos protein expression.
Authors: Honoré P; Physiopharmacologie du Système Nerveux, INSERM U.161 and EPHE, Paris, France., Buritova J, Chapman V, Besson JM
Source: Pain [Pain] 1998 Apr; Vol. 75 (2-3), pp. 281-93.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 7508686 Publication Model: Print Cited Medium: Print ISSN: 0304-3959 (Print) Linking ISSN: 03043959 NLM ISO Abbreviation: Pain Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0304-3959
DOI:10.1016/s0304-3959(98)00006-2